Deepa Sikriwal

Title: Deepa Sikriwal: Innovator in Vaccine Development

Introduction

Deepa Sikriwal is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of vaccine development, particularly in creating formulations that enhance the efficacy and stability of vaccines. With a total of 3 patents to her name, her work is pivotal in addressing public health challenges.

Latest Patents

One of her latest patents is titled "Process for production of purified recombinant cholera toxin B (rCTB) and formulation thereon." This invention relates to a novel process for producing purified recombinant cholera toxin B, which provides protection against diarrhea caused by various bacteria, including Enterotoxigenic E. coli (ETEC). The process boasts significantly higher yield and purity, along with a vaccine formulation that offers synergistic protection against ETEC.

Another notable patent is the "Thermostable spray dried rotavirus vaccine formulation and process thereof." This invention presents an improved thermostable spray dried rotavirus vaccine formulation. It is designed to enhance heat stability, ease of use, and affordability, making it suitable for vaccination programs in developing and low-income countries.

Career Highlights

Deepa has worked with esteemed organizations such as MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. Her experience in these companies has allowed her to contribute to groundbreaking research and development in the field of vaccines.

Collaborations

Throughout her career, Deepa has collaborated with notable professionals, including Davinder Gill and Tarun Sharma. These collaborations have further enriched her research and innovation efforts.

Conclusion

Deepa Sikriwal's contributions to vaccine development are invaluable, particularly in the context of public health. Her innovative patents reflect her commitment to improving vaccine efficacy and accessibility. Her work continues to inspire advancements in the field of immunology.